Alejandro González Veliz: Pregnancy is a Cardiovascular Stress Test
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn about a recent article by Tiffany L Brazile et al, published in The Lancet, adding:
“Pregnancy is one of the most profound cardiovascular stress tests the human body undergoes.
Cardiac output can increase by up to 50% during pregnancy, while systemic vascular resistance falls and blood volume expands. These adaptations are usually well tolerated—but they can also unmask previously unrecognized cardiovascular disease or worsen pre-existing conditions.
And the risk does not end at delivery.
Immediately after birth, haemodynamic changes can be dramatic, with cardiac output rising by 50–80% above pre-labour values. This makes the early postpartum period particularly vulnerable for women with cardiovascular disease.
Cardiovascular disease complicates up to 15% of pregnancies and remains a major contributor to maternal morbidity and mortality worldwide.
The key is not simply recognizing disease—it is identifying risk early.
Preconception counselling, structured risk stratification, medication review, individualized delivery planning, and coordinated care through a pregnancy heart team can make a critical difference.
Most importantly, cardiovascular care should not stop after delivery. Pregnancy and the postpartum period represent an opportunity to identify cardiovascular risk and improve a woman’s long-term cardiovascular health.
Pregnancy is not only an obstetric event.
It is a cardiovascular stress test—and an important window into lifetime cardiovascular health.”
Title: Cardiovascular disease in pregnancy: physiology, global burden, risk stratification, and opportunities in care
Authors: Tiffany L Brazile, Nathalie Conrad, Lina Bergman, Justin Paul Gnanaraj, Laxmi S Mehta, Candice K Silversides, Karen Sliwa, Garima Sharma, Cardiovascular Disease in Pregnancy Writing Group
Other posts featuring Alejandro González Veliz on Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters